Regulations Across ASEAN

Covering Audit, Recall, Pseudoephedrine, Iran, BPK. This episode covers key regulatory developments including deposit insurance audit in Indonesia, Singapore's recall of pseudoephedrine syrup, Iran-related designations, and BPK audit readiness in Indonesia. Topics span audit, recall, pseudoephedrine, Iran, and BPK sectors.

Show Notes

This episode delivers comprehensive updates on critical regulatory matters across ASEAN with a focus on audit processes, product recalls, pharmaceutical regulations, Iran-related sanctions, and audit preparedness involving BPK.

Significant developments include Indonesia’s Deposit Insurance Corporation initiating phased payouts to depositors of a revoked bank license, ensuring compliance with strict criteria. Singapore has launched a retail-level recall of Decondine Syrup batches containing pseudoephedrine due to quality deviations, emphasizing consumer safety. Additionally, Indonesia’s BPK audit collaboration with BNN aims to enhance anti-narcotics program performance.

Environmental enforcement in Jakarta advances with sanctions on illegal waste dumping and fuel misuse, while Singapore clarifies health supplement regulatory frameworks and discontinues certain pharmaceutical education programs.

For more information, visit the Carver Agents website.

Articles mentioned:
  1. Berikan Rasa Tenang Kepada Nasabah, LPS Siapkan Pembayaran Simpanan Nasabah BPRS Hasanah Mandiri
  2. Pemprov DKI Mulai Terapkan Controlled Landfill secara Bertahap di Bantargebang Mulai 1 Agustus
  3. Video CCTV Viral Ditindak Cepat, Pembuang Sampah Liar di Grogol Selatan Didenda Rp500 Ribu
  4. Respons Cepat dan Tegas, Sudin LH Jakut Tindak Pengemudi yang Salahgunakan BBM Operasional
  5. How health supplements are regulated by HSA
  6. Recall of Decondine Syrup
  7. Iran-related Designations; Iran-related and Counter Terrorism Designation Update; Issuance of Iran-related General License
  8. SOFT ENTRY MEETING BPK, BNN SIAP DIAUDIT DEMI PENINGKATAN KINERJA PELAKSANAAN PROGRAM P4GN
  9. Israel Customs and the Bureau of Customs of the Philippines Sign a Joint Action Plan to Advance a Mutual Recognition Agreement for Authorized Economic Operator Programs
  10. Update on the Risk Management Plan of Jinarc® (tolvaptan): Discontinuation of Healthcare Professional (HCP) Education and Certification and related requirements

What is Regulations Across ASEAN?

Regulatory news, updates, and insights for countries in the ASEAN region presented by the Carver Agents team

Welcome to Carver's ASEAN Regulatory Updates for July 19, 2026.

In Indonesia, the Indonesia Deposit Insurance Corporation, known as LPS, has initiated the phased payment of insured deposits following the revocation of BPRS Hasanah Mandiri’s banking license effective July 16, 2026. LPS will complete reconciliation and verification of deposit data within 90 working days from the license revocation date, with payments to depositors to be made in phases no later than November 20, 2026. Depositors must ensure their accounts meet LPS’s 3T criteria: recorded in the bank’s books, interest rates not exceeding the LPS guarantee rate, and absence of criminal acts harming the bank.

Also in Indonesia, the Provincial Government of DKI Jakarta will begin a gradual implementation of controlled landfill practices at Bantargebang starting August 1, 2026. This initiative replaces open dumping with controlled landfill methods to increase waste processing capacity and reduce open dumping by 2028. Improvements include geomembrane covering, sanitation, and slope stabilization.

Enforcement of environmental regulations continues in Jakarta, where individuals caught illegally dumping waste in Grogol Selatan face administrative fines of 500,000 Indonesian Rupiah. This action is based on Peraturan Daerah Provinsi DKI Jakarta Nomor 3 Tahun 2013 Pasal 130 ayat (1) huruf b.

In North Jakarta, the Sudin Lingkungan Hidup has sanctioned a driver with a formal warning and compensation payment for misuse of operational fuel.

Turning to Singapore, the Health Sciences Authority has clarified that health supplements do not require pre-market approval or evaluation but must comply with safety and quality safeguards. These include prohibitions on medicinal ingredients such as steroids, strict limits on toxic heavy metals, and ensuring product claims are not false or misleading.

Additionally, Singapore has initiated a retail-level recall of Decondine Syrup batches containing pseudoephedrine and triprolidine. The recall follows out-of-specification results for triprolidine assay, pH, and viscosity. All affected batches within expiry must cease supply immediately and be returned to the company.

In the Philippines, the Bureau of Customs has signed a Joint Action Plan with Israel Customs to advance a Mutual Recognition Agreement for Authorized Economic Operator programs. This agreement aims to simplify customs procedures and expedite cargo clearance for AEO-certified companies.

Finally, in Singapore, Otsuka Pharmaceuticals will discontinue the Healthcare Professional Education and Certification programme and the verification of prescribing checklists against stock balances for Jinarc® (tolvaptan). Blood test requirements for hepatic transaminases and bilirubin, as well as the distribution of patient education materials, will continue.

That wraps up today's regulatory updates. Visit carveragents.ai for more information.